X

Vous n'êtes pas connecté

Maroc Maroc - NEWS.MEDICAL.NET - A la Une - 07/Aug 05:45

METRNL protein identified as key player in cancer progression

A protein called Meteorin-like (METRNL) in the tumor microenvironment saps energy from T cells, thereby severely limiting their ability to fight cancer, according to new research directed by investigators at the Johns Hopkins University School of Medicine and the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy. Finding ways to block the effects of METRNL signaling on tumor-infiltrating T cells may allow these immune cells to regain the energy necessary to eliminate tumors.

Articles similaires

Sorry! Image not available at this time

Scientists discover key metabolic switch that could boost cancer immunotherapy

knowridge.com - 02/Sep 14:05

A recent study by Ludwig Cancer Research has uncovered a crucial metabolic switch in the immune system’s T cells that plays a vital role in creating...

Researchers discover how body's natural killer cells protects from cancer

times of india - 29/Aug 10:34

Scientists at the University of Southampton have uncovered how the immune system's natural killer cells can target a protein known as XPO1, which...

Research spotlight: Key regulators of pd-1 in melanoma cells and the immune system’s response

oncologynews.com.au - 30/Aug 13:57

Immune checkpoint inhibitors are cancer-fighting drugs that help the immune system do its job of detecting and attacking tumour cells. Programmed Cell...

Combo immunotherapy produces distinct waves of cancer-fighting T cells with each dose

oncologynews.com.au - 02/Sep 16:08

A new tool for monitoring immune health patterns over time has revealed how a pair of checkpoint inhibitor therapies work together to recruit new...

Sorry! Image not available at this time

NEW ARTICLE: MEBENDAZOLE and Thyroid Cancer – Inhibits Tumor Growth and Prevents Lung Metastasis – Shocking New Johns Hopkins Research on Fenbendazole’s Sister Drug

amg-news.com - 02/Sep 14:45

NEW ARTICLE: MEBENDAZOLE and Thyroid Cancer – Inhibits Tumor Growth and Prevents Lung Metastasis – Shocking New Johns Hopkins Research on...

Distinct waves of T cells generated by each dose of combination immunotherapy

news.medical.net - 29/Aug 16:40

A new tool for monitoring immune health patterns over time has revealed how a pair of checkpoint inhibitor therapies works together to recruit new...

Old chemo drug, new pancreatic cancer therapy?

oncologynews.com.au - 28/Aug 16:12

Cold Spring Harbor Laboratory Professor Douglas Fearon discovered that treating pancreatic cancer with a common chemotherapy drug makes immunotherapy...

Scientists discover how the body’s killer cells attack cancer

oncologynews.com.au - 02/Sep 15:41

Scientists are on the verge of a cancer breakthrough after working out how the body’s immune system targets cells devastated by the disease. A new...

New immunotherapy approach shows promise for minimizing spinal cord injury damage

news.medical.net - 04/Sep 16:22

WashU Medicine researchers have designed, in mice, an approach to minimizing the damage from a spinal cord injury through the use of engineered immune...

New immunotherapy approach shows promise for minimizing spinal cord injury damage

news.medical.net - 04/Sep 16:22

WashU Medicine researchers have designed, in mice, an approach to minimizing the damage from a spinal cord injury through the use of engineered immune...

Les derniers communiqués

  • Aucun élément